You are here

Resource Center

AdvaMed Comments on Docket No. FDA-2017-N-5925: Request for Information: Standard Development Organizations Whose Susceptibility Test Interpretive Criteria Standards May Be Recognized by the Food and Drug Administration

Comments

application/pdf - 183.22 kB
Date:
11/29/2017
Issues: